Filtered By:
Source: Pain Physician
Drug: Remicade
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis
Rheumatol Int. 2021 Nov 1. doi: 10.1007/s00296-021-05024-w. Online ahead of print.ABSTRACTAlthough tumor necrosis factor inhibitors (TNFi) have favorably altered the treatment landscape for patients with axial spondyloarthritis (axSpA), there is limited data regarding TNFi persistence and reasons for discontinuation. This is an observational time-to-event study utilizing data collected for a prospective multiple-disease registry of US Veterans with axSpA treated with TNFi therapies and recruited over a 10 year period. Clinical, serological, and comorbid parameters were collected. Corporate Data Warehouse Pharmacy files pro...
Source: Pain Physician - November 1, 2021 Category: Anesthesiology Authors: Delamo I Bekele Elizabeth Cheng Andreas Reimold Christian Geier Kavya Ganuthula Jessica A Walsh Daniel O Clegg Maureen Dubreuil Prashant Kaushik Bernard Ng Elizabeth Chang Ryan Duong Jina Park Gail S Kerr Source Type: research
